INTRODUCTION
============

Sphingolipids, such as ceramide and its metabolites, have recently been recognized as important compounds as secondary messengers involved in signal transduction. They activate ceramide-mediated phosphatases and kinases to stimulate the apoptotic pathways and inhibit cancer cell growth \[[@B1]-[@B3]\]. They are also involved in cell division, differentiation, inflammation, and smooth muscle cell relaxation \[[@B4]-[@B7]\]. Some anticancer agents were reported to induce intracellular ceramide accumulation \[[@B8]\], which led to cell cycle arrest and apoptosis in tumor cells \[[@B9]-[@B11]\]. However, cellular ceramide is rapidly removed by ceramide metabolizing enzymes like ceramidase.

Because ceramide induces apoptosis in cancer cells, ceramide analogues are being considered as therapeutic agents for cancer cells \[[@B12]-[@B17]\]. The introduction of a phenyl ring into the long alkyl chain moiety of ceramide as in D-e-MAPP was shown to enhance ceramidase inhibition and increase intracellular ceramide concentration \[[@B18],[@B19]\]. The aromatic analogues of ceramide, such as D-e-MAPP with 1S, 2R configuration and B13 with 1R, 2R configuration rather than 2S, 3R configuration of natural ceramide, inhibit ceramidase to induce apoptosis ([Fig. 1](#F1){ref-type="fig"}). In this way, they exhibit potent cytotoxicity against various cancer cells including leukemia, colon, and prostate cancer cells \[[@B20]-[@B25]\]. Furthermore, B13 showed selective cytotoxicity toward malignant cells but not normal cells and prevented colon cancer cells from the transition to metastasis in a nude mouse model \[[@B9]\].

The amide group of ceramide can be isosterically replaced by urea or an amine group to increase inhibitory activity against ceramidase and to promote cytotoxicity \[[@B25]\]. The B13 sulfonamides are assumed to exhibit biological activities similar to that of B13, since they were made by bioisosterically substituting the carboxyl moiety in B13 with a sulfone group. Sulfonamides are also known to have various biological activities acting as hypoglycemic, diuretic, and antibacterial agents \[[@B26]-[@B28]\]. Recently, some sulfonamides have been reported to demonstrate anticancer activity \[[@B29]-[@B32]\].

As a continuation of our previous reported work \[[@B33]\] and as an extension of those findings, we report here on the cytotoxicities of twenty B13 sulfonamide analogues against human colon and lung cancer cell lines and evaluate the influence of the stereochemistry of 1,3-propandiol, the p-nitro group in the phenyl ring, and alkyl chain length in the sulfonamide moiety. We also carry out QSAR analysis to investigate the relationship between the structural features and cytotoxicity of B13 sulfonamide analogues.

METHODS
=======

Chemicals
---------

Phosphate-buffered saline (PBS) was bought from Boehringer Mannheim. Dimethyl sulfoxide (DMSO), 3-\[4,5-dimethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide (MTT), and other reagents were obtained from Sigma.

In vitro cytotoxic assay
------------------------

The cytotoxic activities of B13 sulfonamides which were synthesized in our lab were estimated in two human tumor cell lines: colon cancer HT-29 and lung cancer A549. The results from the cytotoxic assays are illustrated in [Table 1](#T1){ref-type="table"} and a description of the MTT-based colorimetric assay used is included in the legend for that Table \[[@B34]\].

Data sets and values
--------------------

Twenty-one compounds were used to perform QSAR analysis. The molecular structures of the training and test sets are shown in [Table 1](#T1){ref-type="table"}. The data set was divided into two groups. Based on their different alkyl chain lengths and R, S configurations at C~1~ and C~2~, four compounds (1, 10, 12, 18) were selected for the test set, which was used for external validation of the QSAR models. The rest of the 17 compounds including B13 were used for the training set. All IC~50~ values were converted into pIC~50~ (-log IC~50~) values which were then used as the dependent values to derive CoMFA and CoMSIA.

Molecular modeling
------------------

We used Sybyl-X 1.2 program for modeling molecules, performing partial least squares (PLS), and conducting CoMFA and CoMSIA \[[@B35]\]. Molecular structures were designed with a sketch tool and optimized using a TRIPOS force field with the Gasteiger Huckel charges and conjugated gradient method. The conformations with low energy were analyzed by simulated annealing and were aligned using the fitting atoms method. The propyl moiety (C~1~-C~2~-C~3~) marked as a bold line in [Table 1](#T1){ref-type="table"} was used as a common substructure and the most active compound (15) was used as a template molecule in alignment.

CoMFA and CoMSIA
----------------

CoMFA was executed in the steric and electrostatic fields with the default values. Aligned molecules were put into the three dimensional cubic lattice with a grid spacing of 2.0 Å. The energy cutoff was the default value of 30 kcal/mol. The Lennard-Jones potential and Coulombic potential were applied to calculate the steric and electrostatic field energies of CoMFA, respectively. The sp^3^ probe carbon atom with a charge of +1 and a Van der Waals radius of 1.52 Å was used to create the CoMFA steric and electrostatic fields. The CoMSIA concerns five properties (steric, electrostatic, hydrophobic, hydrogen bond acceptor, and hydrogen bond donor fields) using a common probe atom with radius 1.0 Å, charge +1, hydrophobicity +1, hydrogen bond donating +1, and hydrogen bond accepting +1.

Partial least square (PLS) analysis
-----------------------------------

In the PLS analysis, the leave-one-out method of cross-validation was carried out to determine the optimum number of components, which were then used for the non cross-validated analysis. In the leave-one-out method, one compound was removed from the data set and its biological activity was predicted with the model derived from the rest of the data set.

RESULTS
=======

In vitro cytotoxic activity
---------------------------

The cytotoxicities of twenty-one B13 sulfonamides against human colon cancer HT-29 and lung cancer A549 cell lines were estimated *in vitro*. Their biological activities are summarized in [Table 1](#T1){ref-type="table"} and B13 itself showed moderate cytotoxicity with IC~50~ values of 68.4 and 94.2μM for HT-29 and A549 cells, respectively. In colon cancer HT-29 cells, most of the sulfonamides except for the short alkyl chain (C~7~H~15~ and C~8~H~17~) compounds (1, 2, 6, 7, 11, 16, 17) showed more potent activities than B13. The cytotoxicities of the long alkyl chain (C~13~H~27~) analogues (5, 10, 15, 20) were increased two times that of B13 to give IC~50~ values of 35.9, 39.2, 27, and 30.8μM, respectively, in HT-29 cells. Compounds (11\~20) with a C~3~-OH and *para* nitro group in the phenyl ring had stronger activities than compounds (1\~10) which did not have these groups. For lung cancer A549 cells, the long alkyl chain compounds exhibited more potent cytotoxicities than the short alkyl chain compounds. Some of the long alkyl chains (C~11~H~23~ and C~13~H~27~) analogues (4, 5, 14, 15, 19, 20) showed almost two-fold increases in activity with IC~50~ values of 46, 49.3, 41.1, 28.7, 40.9, and 30.8μM, respectively. Compounds (5, 10, 15, 20) with long alkyl chain (C~13~H~27~) were much more active than B13 against both tumor cell lines and exhibited IC~50~ values of 35.9, 39.2, 27, and 30.8μM, respectively, against colon cancer HT-29 cell lines and 49.3, 80.7, 28.7, and 30.8μM, respectively, against lung cancer A549 cell lines. The IC~50~ values of the other compounds ranged from 25.7 to 191.5μM for HT-29 cells and 40.9 to 267.3μM for A549 cells.

3D-QSAR analysis
----------------

The statistical data from CoMFA and CoMSIA models are illustrated in [Table 2](#T2){ref-type="table"}. All CoMFA and CoMSIA models were based on the training set of 17 compounds and the test set of 4 compounds.

Colon cancer HT-29 cells
------------------------

The CoMSIA model with hydrophobic, hydrogen bond donor, and hydrogen bond acceptor fields gave a cross-validated coefficient (q^2^) value of 0.703 and non-cross-validated coefficient (r^2^~ncv~) value of 0.992 with the optimum number of components of 4; SEE, 0.027; and F value, 396.375. The q^2^ value obtained from this model was higher than those from any other CoMFA and CoMSIA models. The predictive ability of the model was expressed as r^2^~pred~ with a value of 0.929. The predicted pIC~50~ values and residuals for training and test sets are shown in [Tables 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, respectively. A graph of actual *versus* predicted pIC~50~ values for the training and test sets is illustrated in [Fig. 2](#F2){ref-type="fig"}.

Lung cancer A549 cells
----------------------

The CoMSIA model with hydrophobic and hydrogen bond acceptor fields was used to calculate the cross-validated coefficient (q^2^), non-cross-validated coefficient (r^2^~ncv~), and optimum number component (N) to give values of 0.830, 0.990, and 4, respectively. With this model, the predicted r^2^ value (r^2^~pred~) was 0.832 and the predicted pIC~50~ values and residuals of the training set and test set are summarized in [Tables 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, respectively. [Fig. 2B](#F2){ref-type="fig"} describes the correlation between the actual *versus* predicted pIC~50~ values of the compounds in the training and test sets.

DISCUSSION
==========

As described in the *in vitro* bioassay, compound (15) showed the most potent activity against both colon cancer HT-29 and lung cancer A549 cell lines with IC~50~ values of 27.0 and 28.7μM, respectively. B13 sulfonamides with a C~13~H~27~ alkyl chain (5, 15, 10, 20) showed two or three times more potent cytotoxicities than B13 which also had a C~13~H~27~ alkyl chain, suggesting that introduction of a sulfonamide group into B13 increased its cytotoxicity. The stereochemistry of 1,3-propandiol was not important for cytotoxicity in compounds with alkyl chains of the same length, although some (1R, 2R)-compounds (12, 13, 15) manifested stronger cytotoxicities than the (1S, 2S)-compounds (16, 18, 20), which had slightly more potent activities than the (1R, 2S)-compounds (2, 4, 5) and (1S, 2R)-compounds (7, 8, 9). The compounds with a para nitro group at the phenyl ring and a C~3~-OH group (13, 15, 18, 20) demonstrated higher activities than the compounds without them (3, 5, 8, 10). In general, compounds with long alkyl chains (5, 10, 15, 20) exhibited enhanced activity compared to those with short alkyl chains (1, 6, 11, 16). This finding was consistent with the reported trend that cytotoxicity increased with an increase in the acyl chain length of ceramide \[[@B36]\].

In the CoMSIA model of colon cancer HT-29 cells, the cross-validated coefficient (q^2^) value was 0.703 and was considered sufficiently predictive for validation because it was greater than 0.6. The relative contributions of the hydrophobic field (44.2%), hydrogen bond donor field (26.9%), and hydrogen bond acceptor field (29%) indicated that the phenyl ring and long alkyl chain for hydrophobicity, the hydrogen atom of sulfonamide as a hydrogen bond donor, oxygen atoms of the C~1~-OH and sulfone group as hydrogen bond acceptors contributed to cytotoxicity. For lung cancer A549, the CoMSIA model with hydrophobic and hydrogen bond acceptor fields yielded high q^2^ (0.830) and r^2^~ncv~ (0.990) values which represented a precise predictivity for this model. The contributions of the hydrophobic field (58.7%) and hydrogen bond acceptor field (41.3%) indicated that strong hydrophobic ligand-receptor interactions were involved in the cytotoxicities of the compounds. The small average residual values (0.02) between actual and predicted activities in [Table 3](#T3){ref-type="table"} demonstrated that the predicted activity from the CoMSIA models correlated well with actual activity. The test set was used to validate the predictive ability of these CoMSIA models and their small average residual values (0.06 and 0.08) showed that both models accurately predicted the cytotoxicities of test set molecules.

The CoMSIA contour maps illustrate the structural features important for potent activity to show regions around molecules, in which increased or decreased activity was expected by physicochemical property changes. In [Fig. 3](#F3){ref-type="fig"}, the yellow contours indicate regions where a hydrophobic group would increase the biological activity, whereas the white ones would decrease the activity.

The cyan and purple contours denote the places where a hydrogen bond donor would be favorable and unfavorable, respectively. The magenta regions represent areas that are favorable for a hydrogen bond acceptor, while red regions indicate areas unfavorable for such a group. The molecule used in the contour maps is compound (15), which showed the most potent cytotoxicity.

The CoMSIA contour map of colon cancer HT-29 cells ([Fig. 3A](#F3){ref-type="fig"}) presents yellow contours at *ortho* and *meta* positions of the phenyl ring. These yellow contours suggest that hydrophobic groups at these regions would enhance cytotoxicity and that the introduction of a naphthyl ring instead of a phenyl ring would increase activity. This finding was supported by the compounds (1, 6, 11) in which yellow contours were superimposed with oxygen atoms of sulfonamide and C~1~-OH groups to show much lower activities than other compounds with IC~50~ values of 191.5, 183, and 101μM, respectively. The cyan contours near the hydrogen atoms of sulfonamide in compounds (5, 15) and the C~3~-OH group in compound (20) coincided with regions favorable for a hydrogen bond donor and the magenta contours around the oxygen atoms of the C~1~-OH and sulfonamide groups in compounds (5, 15, 20) corresponded to favorable hydrogen bond acceptor regions helping to account for their high potency. The CoMSIA contour map of lung cancer A549 cells ([Fig. 3B](#F3){ref-type="fig"}) illustrated yellow contours at *ortho* and *meta* positions of the phenyl ring and the alkyl chain in compounds (5, 15, 20), where they were in accord with hydrophobically favorable regions to produce strong cytotoxic activities. It was also shown that the favorable hydrogen bond acceptor regions (magenta contour) were near the oxygen atoms of C~1~-OH and sulfonamide groups, while unfavorable regions (red contour) were located around the alkyl side chain in compounds (5, 15, 20). These regions correlated well with the contour map to explain their potent cytotoxicity.

In conclusion, compounds (5, 15, 20) exhibited stronger cytotoxicities than B13 in both tumor cell lines. The good predictivity of the CoMSIA models was illustrated by high q^2^ (0.703 and 0.830) and r^2^~ncv~ (0.992 and 0.990) coefficient values. The small average residual values of the training (0.02) and test (0.06 and 0.08) sets indicated that the predicted activities from CoMSIA models correlated well with the actual activities. Cytotoxic assays demonstrated that the stereochemistry of 1,3-propandiol was not important for activity and that a sulfonamide group and long alkyl chain increased the cytotoxicity of the compounds. Furthermore, the introduction of a naphthyl ring in place of the phenyl ring was suggested to increase hydrophobicity and cytotoxicity.
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![Structure of ceramide and B13 analogues.](kjpp-15-423-g001){#F1}

![Graph of the actual *versus* predicted activities for training and test set compounds. (A) Colon cancer HT-29 cells. (B) Lung cancer A549 cells. The IC~50~ values were transformed into pIC~50~ (-log IC~50~) values (●: training set molecules, ▲: test set molecules).](kjpp-15-423-g002){#F2}

![3D-contour maps of CoMSIA models. (A) CoMSIA model with hydrophobic, hydrogen bond donor, and hydrogen bond acceptor fields for colon cancer HT-29 cells. (B) CoMSIA model with hydrophobic and hydrogen bond acceptor fields for lung cancer A549 cells. Compound (15) is shown within the fields (yellow, favorable hydrophobicity; white, unfavorable hydrophobicity; cyan, favorable hydrogen bond donor; purple, unfavorable hydrogen bond donor; magenta, favorable hydrogen bond acceptor; red, unfavorable hydrogen bond acceptor).](kjpp-15-423-g003){#F3}

###### 

Structures and in vitro cytotoxicities of B13 sulfonamide analogues
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The cells were plated at a density of approximately 1×10^4^ cells/well in 96-well plates. Each well contained 180µl of medium into which 20µl of 10×concentration of prepared compounds or PBS were added. After 96h of culture, 0.1mg of MTT was added to each well and incubated at 37℃ for 4 h. The plates were centrifuged at 450×g to precipitate the formazan crystals. The medium was removed and 150µl of DMSO was added to each well to dissolve the formazan. In this assay, MTT was converted to blue formazan by mitochondrial dehydrogenase. The intensity of the blue color was measured with a microplate reader at a wavelength of 540 nm. The mean measured values are expressed as the IC~50~, the concentration that reduced the optical density of the treated cells by 50% with respect to the untreated controls.

###### 

Statistical data of CoMFA and CoMSIA models
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^a^Fields used (S, steric; E, electrostatic; H, hydrophobic; D, H-bond donor; A, H-bond acceptor); ^b^q^2^, cross-validated correlation coefficient from leave-one-out (LOO); ^c^N, optimum number of components; ^d^SEP, standard error of prediction; ^e^r^2^~ncv~, non-cross-validated correlation coefficient; ^f^SEE, standard error of estimate; ^g^F, F-test value; ^h^r^2^~pred~, predicted correlation coefficient.

###### 

Actual versus predicted cytotoxicities (pIC~50~) of the training set
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^a^Actual cytotoxic activity; ^b^predicted activity by the CoMSIA model with hydrophobic, hydrogen bond donor, and hydrogen bond acceptor fields; ^c^difference between the actual and predicted activities; The pIC~50~ (-log IC~50~) values were converted from IC~50~ values.

###### 

Actual versus predicted cytotoxicities (pIC~50~) of the test set
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^a^Actual cytotoxic activity; ^b^predicted activity by the CoMSIA model with hydrophobic and hydrogen bond acceptor fields; ^c^difference between the actual and predicted activities; The pIC~50~ (-log IC~50~) values were converted from IC~50~ values.
